Defining the limits of immunotherapy in early small-cell lung cancer
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer…
Severe COVID and flu infections increase risk of lung cancer
Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease’s development, but vaccination heads off…
Blocking growth hormone receptor may improve treatment response in lung cancer
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is…
Nasal COVID vaccine boost increases IgA responses linked to variant neutralisation
A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering…
Rising lung cancer in never smokers demands urgent research focus
Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer…
Most commercially insured patients live with chronic conditions
The majority (57.5 percent) of commercially insured patients had at least one chronic condition in 2024. The average…
Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread
Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation…
‘It was awful watching my mum get really upset, then having to tell my husband’ – The Irish Times
Most people have experienced symptoms of coronavirus over the past few years, so when Ilana Hastings had feelings…
Can a simple blood test improve seniors’ lives through earlier cancer detection?
Can a simple blood test improve the lives of seniors through early cancer detection? A three-year clinical trial…
Bacterial metabolite enhances immune checkpoint therapy against lung cancer
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response…
Durvalumab extends survival in small cell lung cancer but raises cost concerns
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living…
Inflammation and immune suppression fuel aggressive SCLC behavior and spread
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year…